K Pharma (TSE:4896) Pre-Tax Income : 円-739 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. K Pharma's pretax income for the three months ended in Jun. 2024 was 円-192 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was 円-739 Mil. K Pharma's pretax margin was %.

During the past 3 years, K Pharma's highest Pretax Margin was 30.11%. The lowest was 30.11%. And the median was 30.11%.

K Pharma Pre-Tax Income Historical Data

The historical data trend for K Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Pre-Tax Income Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Pre-Tax Income

-229.12

-390.53

301.08

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24
Pre-Tax Income	Get a 7-Day Free Trial			-	-142.46	-171.00	-232.87	-192.48

Competitive Comparison of K Pharma's Pre-Tax Income

For the Biotechnology subindustry, K Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

K Pharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, K Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where K Pharma's Pre-Tax Income falls into.

K Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

K Pharma's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	366.058	+	0	+	-11.849	+	0.016	+	-53.149
	=	301

K Pharma's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-192.704	+	0	+	0	+	0	+	0.22499999999999
	=	-192

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-739 Mil.

K Pharma (TSE:4896) Pre-Tax Income Explanation

K Pharma's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-192.479	/	0
	=	%

During the past 3 years, K Pharma's highest Pretax Margin was 30.11%. The lowest was 30.11%. And the median was 30.11%.

K Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of K Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma Headlines

No Headlines